ICAP

A Randomized Non-Inferiority Study

A Randomized Non-Inferiority Study to Assess Immunogenicity, Safety, and Acceptability of Two vs. Three Doses of the Nonavalent Human Papillomavirus (HPV) Vaccine Among Children, Adolescents and Young Adults Living with HIV in Eswatini


Status

Upcoming

Locations

Eswatini CTU

Our Approach

Research

Health Challenges

HIV/AIDS

Keywords

HPV